Abstract:OBJECTIVE:To observe the serial changes of plasma microparticle procoagulant activity in patients with traumatic brain injury (TBI) and evaluate its correlations with outcome and pathophysiology of TBI.METHODS:A total of 139 consecutive patients with isolated moderate or severe head trauma and 40 age- and sex-matched healthy controls were enrolled. Plasma samples were obtained on entry in healthy controls, as well as on admission and at day 1, day 2, day 3, day 5, and day 7 after TBI in the patients. Its concentration was measured by a prothrombinase assay.RESULTS:Fifty patients (36.0%) died from TBI in a month. After TBI, plasma microparticle procoagulant activity in the patients increased during the 6-hour period immediately, peaked in 24 hours and decreased gradually thereafter. It was substantially higher than that of healthy controls during the 7-day period using analysis of covariate (P < 0.01). A multivariate analysis selected plasma microparticle procoagulant activity (OR 1.432, 95% CI 1.194-1.719, P < 0. 01) as an independent predictor for 1-month mortality. Plasma microparticle procoagulant activities of non-survivals were statistically significantly higher than those of survivals (P = 0.01), and plasma microparticle procoagulant activities of patients with severe TBI were obviously higher than those of patients with moderate TBI (P = 0.002) using repeated-measures analysis. Plasma microparticle procoagulant activities of patients were negatively associated with Glasgow coma scale scores using Spearman correlation coefficient (P < 0.05). A multivariate linear regression selected plasma D-dimer level (P = 0.012) and plasma C-creative protein level (P = 0.019) related to plasma microparticle procoagulant activities. A receiver operating characteristic curve identified the cutoff levels of plasma microparticle procoagulant activities (12.2 U/ml) predicting 1-month mortality of patients with the high sensitivity (72.0%) and specificity values (85.4%). Areas under curve (AUC) of plasma resistin level (AUC = 0.847 +/- 0.037) was smaller than those of GCS scores (AUC = 0.917 +/- 0.023), but this difference failed to reach statistical significance (P = 0.104).CONCLUSION:Increased activity of plasma microparticle procoagulant is found after traumatic brain injury. It may contribute to inflammatory reaction and coagulation cascade and is associated with a poor clinical outcome.

Attach Importance to the Early Diagnosis and Treatment of Acute Coagulation Dysfunction after Major War Trauma

Research progress in diagnostic strategies of trauma-induced coagulopathy

The Pathophysiology and Management of Acute Traumatic Coagulopathy.

Change in Plasma Microparticle Procoagulant Activity after Traumatic Brain Injury

Coagulation changes after severe head traumas

Validating the Incidence of Coagulopathy and Disseminated Intravascular Coagulation in Patients with Traumatic Brain Injury – Analysis of 242 Cases

A time course study of acute traumatic coagulopathy prior to resuscitation: from hypercoagulation to hypocoagulation caused by hypoperfusion?

Severe Trauma-Induced Coagulopathy: Molecular Mechanisms Underlying Critical Illness

Pathophysiology of Trauma-Induced Coagulopathy

Research and Application Progress of Examination on Coagulation Function in Trauma Patients

Chinese expert consensus on diagnosis and treatment of trauma-induced hypercoagulopathy

Research progress in prevention and treatment of traumatic coagulopathy

Effects Of Recombinant Activated Factor Viia On Abdominal Trauma Patients

Utility of interim ROTEM(®) values of clot strength, A5 and A10, in predicting final assessment of coagulation status in severely injured battle patients

CORRECTION OF TRAUMA-INDUCED COAGULOPATHY BY GOAL DIRECTED THERAPY: A SECONDARY ANALYSIS OF THE ITACTIC TRIAL

Coagulopathy and Traumatic Brain Injury: Overview of New Diagnostic and Therapeutic Strategies

Traumatic brain injury: Advances in coagulopathy (Review)

Correlation Between Coagulation-Fibrinolysis and Progressive Intracranial Hemorrhage and Prognosis in Patients with Acute Traumatic Brain Injury

Viscoelastic haemostatic assay augmented protocols for major trauma haemorrhage (ITACTIC): a randomized, controlled trial

A machine learning–based Coagulation Risk Index predicts acute traumatic coagulopathy in bleeding trauma patients

Platelet Function Analysis by Flowcytometry in Thrombocytopenic Trauma Patients